The Week in Review: April 28, 2017 – May 5, 2017

Friday, May 5, 2017 News Recap Canada Great news from Nova Scotia: Expanded access to and coverage for treatment of chronic hepatitis C is now available under the provincial Pharmacare plan, similar to the new arrangements in BC, Alberta, Ontario, Saskatchewan and Quebec.  The drugs covered are: Epclusa, Daklinza, Sunvepra, Zepatier, Harvoni and Sovaldi. You can read the Nova Scotia Pharmacare Formulary Updates here (Nova Scotia Lists EPCLUSA™ on P...

Response from Dr. Grebely concerning DAAs & HCC

Below is a letter from Jason Grebely, PhD, Associate Professor The Kirby Institute, UNSW Sydney, concerning a news item we shared from ILC 2017 reporting on what the authors believed was a relationship between DAAs and HCC Higher Risk of HCC Recurrence Observed Following DAA Therapy for Hepatitis C.  We really appreciate getting feedback from medical professionals on these matters because, although we do our best to present "the truth," sometimes it's a bi